{"code":1,"isDone":false,"toInsertArticleList":[{"createdTime":"2020-10-09 12:04:45","updatedTime":"2020-10-09 12:04:45","title":"流感疫苗“超级年”，哪些上市公司有实质利好？","link":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","description":"<div><div><div id=\"media\" class=\"rich_media_thumb_wrp\">\n\n            <img class=\"rich_media_thumb\" src=\"http://img.100weidu.com/mmbiz_jpg/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDBC6qAJR3rAoz0r9Fa4RXHHhgugooTJjrZEKVqUz7PP9kbOroWICnjg?imageView2/1/w/600\">\n        </div>\n    \n\n    \n\n    <div class=\"rich_media_content\" id=\"js_content\">\n                    \n\n                    \n\n                    \n                    \n                    <p><img data-ratio=\"0.5685714285714286\" data-type=\"jpeg\" data-w=\"700\" style=\"background: none 0px center; border-width: 0px; border-style: initial; border-color: initial; margin-right: auto; margin-left: auto; vertical-align: baseline; font: inherit; display: block; width: 700px; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRD05PzkAEVDOWIOib0ro8KVicwwcVZWCAmJyyOCJsy9uUkCeJInLn446CA/640?wx_fmt=jpeg\"></p><p><span style=\"font-size: 14px;color: rgb(136, 136, 136);\">图片来源：视觉中国</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">2020年成为流感疫苗接种“超级年”已是市场共识。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">世界卫生组织近日表示，流感疫苗并不能预防新冠病毒，但希望可以减轻卫生医疗系统的负担。此前，北京疾控中心宣布2020年流感九种接种疫苗于9月底全面启动。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">数据显示，受批签发时间提前所致，今年1-8月国内流感疫苗批签发数量达1054万支，同比增加52%。具体来看，深圳赛诺菲巴斯德生物制品有限公司占比超过一半，达346万支。此外，华兰生物（002007.SZ）、科创板拟上市公司科兴生物、上海生物制品研究所有限责任公司（简称“上海所”）、长春生物制品研究所有限责任公司（简称“长春所”）均获疫苗批签发。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">随着今年流感疫苗呈现爆发，哪些公司将从中实质性获益？</span></p><section style=\"box-sizing: border-box;font-size: 16px;\"><section style=\"margin-top: 10px;margin-bottom: 10px;text-align: center;line-height: 1;box-sizing: border-box;\" powered-by=\"xiumi.us\"><section style=\"width: 0px;display: inline-block;vertical-align: bottom;border-bottom: 1.6em solid rgb(219, 213, 213);border-left: 0.9em solid transparent !important;border-right: 0.9em solid transparent !important;box-sizing: border-box;\"><br></section><section style=\"width: 0px;display: inline-block;vertical-align: bottom;margin-left: -0.6em;border-bottom: 1em solid rgb(183, 5, 5);border-left: 0.6em solid transparent !important;border-right: 0.6em solid transparent !important;box-sizing: border-box;\"><br></section></section></section><h3 style=\"text-align: center;margin: 25px 8px;line-height: 1.75em;\"><strong><span style=\"letter-spacing: 0.5px;font-size: 18px;\">三价流感疫苗：四足鼎立正在改写</span></strong><br></h3><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">由于流感疫苗属于二类自费疫苗，相比国家免疫范围的一类疫苗，利润空间较大。生产流感疫苗为主的华兰生物2019年疫苗制品毛利率可达85.03%。一般而言，疫苗获得批签发后到最终形成销售还需要1-2个月的时间，因此批签发量可以成为“预测”疫苗企业业绩的前置指标。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">国内流感疫苗分为三价与四价两种类型。从2019年流感疫苗批签发量来看，三价流感疫苗约占7成，四价流感疫苗约占3成。三价流感疫苗能预防三种亚型流感病毒。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">2019年，三价疫苗市场形成长春所、赛诺菲巴斯德、华兰生物和科兴生物“四足鼎立”的局面。这四大流感疫苗公司的三价疫苗批签发量产能均接近400万支/年。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">今年，长春所与华兰生物三价疫苗的批签发量远不及理论年产能。1-8月，三价流感疫苗总共批签发629万支，同比增速为12%。其中赛诺菲巴斯德以346万支、55%市场份额列第一，其后依次为科兴生物142万支，华兰生物70万支。而上海所和长春所分别只有43万支和28万支。</span></p><p><img data-ratio=\"0.5314285714285715\" data-type=\"png\" data-w=\"700\" style=\"background: none 0px center; border-width: 0px; border-style: initial; border-color: initial; vertical-align: baseline; font: inherit; display: inline-block; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDibsbBFdyj4Hs89NDgdb8hAml2LrcjlguiaGljCAJ95icwLtzE9ekulGDw/640?wx_fmt=png\"></p><p><span style=\"font-size: 14px;color: rgb(136, 136, 136);\">数据来源：网络、界面新闻研究部</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">实际上，已有多家公司宣布增加今年流感疫苗产能获延长生产周期等措施，预计包括科兴生物等公司下半年批签发量将迅速增加。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">不过这些公司也并没有把所有注意力都放在流感疫苗上。据了解，科兴生物在北京大兴生物医药产业基地的新冠疫苗年产能达3亿支。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">也有其他公司欲打破现有局面。9月28日，长春高新（000661.SZ）表示其子公司百克生物研发的流感疫苗获批签发量达125万支，这款疫苗属于鼻喷流感减毒活疫苗。</span></p><section style=\"box-sizing: border-box;font-size: 16px;\"><section style=\"margin-top: 10px;margin-bottom: 10px;text-align: center;line-height: 1;box-sizing: border-box;\" powered-by=\"xiumi.us\"><section style=\"width: 0px;display: inline-block;vertical-align: bottom;border-bottom: 1.6em solid rgb(219, 213, 213);border-left: 0.9em solid transparent !important;border-right: 0.9em solid transparent !important;box-sizing: border-box;\"><br></section><section style=\"width: 0px;display: inline-block;vertical-align: bottom;margin-left: -0.6em;border-bottom: 1em solid rgb(183, 5, 5);border-left: 0.6em solid transparent !important;border-right: 0.6em solid transparent !important;box-sizing: border-box;\"><br></section></section></section><h3 style=\"text-align: center;margin: 25px 8px;line-height: 1.75em;\"><strong><span style=\"letter-spacing: 0.5px;font-size: 18px;\">四价流感疫苗：华兰生物将成最大受益者</span></strong><br></h3><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">四价流感疫苗是另一款重要品种，占比约三成。一般认为，由于四价疫苗在流感预防亚型数量上有优势，与三价流感疫苗存在一定替代关系。市场对流感疫苗需求突增，“供不应求”成为常态。目前，四价疫苗市场份额增长主要受制于产能。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">今年1-8月四价流感疫苗批签发量达425万支，同比大幅增加224%。其中华兰生物（002007.SZ）批签发量289万支，同比增加121%，市场份额达68%。2019年，华兰生物批签发量836万支，市场份额达86%。今年其他获得四价流感疫苗批签发的公司还包括长春所77万支，金迪克生物60万支。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">从数据来看，华兰生物依旧是四价流感疫苗的领跑者。此前华兰生物董秘在接受媒体采访时表示，今年流感疫苗产量将同比翻倍，预计三价流感疫苗产量将达300万支，四价流感疫苗将达到1600万支以上。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">值得留意的是，华兰生物2019年三价流感疫苗批签发数量超过400万支，今年规划却仅为300万支。显然华兰生物开始把疫苗产能向利润更高的四价流感疫苗倾斜。9月22日，华兰生物在互动平台表示，正陆续将批签发合格的四价流感疫苗运往全国各地。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">华兰生物有望凭借今年流感疫苗出货量及疫苗制品实现业绩“翻倍”。2019年华兰生物疫苗制品板块实现收入10.43亿元，按85.03%毛利率估算，毛利达8.87亿元，预计2020年华兰生物疫苗制品板块毛利可以达17.74亿元。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">华兰生物上半年业绩表现平平，实现收入13.87亿元，同比减少1.15%，实现归母净利润5.12亿元，同比微增0.94%。主要受血液制品相关收入减少，及疫苗制品业绩主要集中在下半年所致。即使如此，市场已经反映了对公司全年业绩的预期，截至9月30日收盘，今年以来华兰生物股价涨幅达112.51%。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">华兰生物疫苗板块也得到了资本的青睐。今年3月，华兰生物宣布接受高瓴骅盈和晨壹启明20.7亿元投资；4月，华兰生物又宣布分拆华兰疫苗至创业板上市，目前华兰疫苗处于上市辅导期。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><span style=\"font-size: 16px;letter-spacing: 0.5px;\">华兰生物自身业务相对复杂，也许是分拆华兰疫苗独立上市的原因之一。除了血液制品、疫苗制品两大板块以外，华兰生物还涉足生物制药板块。华兰生物2020年中报显示，阿达木单抗、曲妥珠单抗、利妥昔单抗、贝伐单抗目前处于临床Ⅲ期。</span></p><p style=\"text-align: justify;margin: 25px 8px;line-height: 1.75em;\"><br></p><section data-role=\"outer\" label=\"Powered by 135editor.com\" style=\"font-size: 16px;\"><section data-role=\"outer\" label=\"Powered by 135editor.com\"><section data-tools=\"135编辑器\" data-id=\"87459\" data-color=\"#212122\" data-custom=\"#212122\"><section style=\"box-sizing: border-box;font-size: 16px;\"><section style=\"margin-top: 10px;margin-bottom: 10px;text-align: center;box-sizing: border-box;\" powered-by=\"xiumi.us\"><section style=\"display: inline-block;vertical-align: top;box-sizing: border-box;\"><section style=\"width: 12px;height: 12px;margin-left: -1px;border-top: 3px solid rgb(249, 110, 87);border-left: 3px solid rgb(249, 110, 87);transform: rotate(0deg);-webkit-transform: rotate(0deg);-moz-transform: rotate(0deg);-o-transform: rotate(0deg);box-sizing: border-box;\"><br></section><section style=\"margin-top: -11px;margin-bottom: -11px;border-width: 1px;border-style: solid;border-color: rgb(223, 223, 223);padding: 4px;box-sizing: border-box;\"><section style=\"border-width: 1px;border-style: solid;border-color: rgb(223, 223, 223);padding-left: 6px;padding-right: 6px;font-size: 18px;letter-spacing: 1px;box-sizing: border-box;\"><p style=\"box-sizing: border-box;\"><strong style=\"box-sizing: border-box;\">未经授权 禁止转载</strong></p></section></section><section style=\"width: 12px;height: 12px;margin-left: auto;margin-right: -1px;border-bottom: 3px solid rgb(249, 110, 87);border-right: 3px solid rgb(249, 110, 87);transform: rotate(0deg);-webkit-transform: rotate(0deg);-moz-transform: rotate(0deg);-o-transform: rotate(0deg);box-sizing: border-box;\"><br></section></section></section></section><section style=\"text-align: center;margin-top: 10px;margin-bottom: 10px;\"><br></section><section style=\"text-align: center;margin-top: 10px;margin-bottom: 10px;\"><img width=\"auto\" class=\"__bg_gif\" data-ratio=\"0.5628571428571428\" data-type=\"gif\" data-w=\"700\" style=\"font-family: mp-quote, -apple-system-font, system-ui, Arial, sans-serif; font-size: 17px; width: auto !important; visibility: visible !important; box-sizing: border-box !important; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/l4sfibEYR5pUf979ZOSA6TqRcPELjZicZo5sJYxcicsfdcNjPpiaE8S9RyQJET6FF1iaqnx3ptoXFnx3UgCsIn6wE3w/640?wx_fmt=gif\"><br></section></section></section></section>\n                </div>\n\n    \n        <br>\n        <div id=\"js_toobar3\" class=\"rich_media_tool\">\n            <a target=\"_blank\" href=\"https://www.jiemian.com/article/5084023.html\" id=\"js_view_source\" class=\"media_tool_meta meta_primary\">阅读原文</a>\n        </div>\n    \n    <br>\n\n    \n        <a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MjM5NTE0ODc2Nw==&amp;mid=2650485648&amp;idx=3&amp;sn=30569cb08db14441d033aed88c045dae&amp;chksm=bef375208984fc36eadcd5a26c585be5b6fce95c3f28ebe6c09bb6fad546c1f8b354af77a7a9&amp;scene=0#rd\" style=\"color: blue\" class=\"media_tool_meta meta_primary\">原文</a>\n        <br>\n    \n\n    \n\n    <img alt=\"\" width=\"1px\" height=\"1px\" class=\"\" style=\"width:1px;height:1px;display:none\" src=\"http://www.jintiankansha.me/rss_static/32521/BrDLFR55zs\"></div></div>","descriptionType":"html","publishedDate":"Thu, 08 Oct 2020 12:42:00 +0000","feedId":1597,"bgimg":"http://img.100weidu.com/mmbiz_jpg/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDBC6qAJR3rAoz0r9Fa4RXHHhgugooTJjrZEKVqUz7PP9kbOroWICnjg?imageView2/1/w/600","linkMd5":"57c2f7e6ee7f588aab50e11afadf5f21","bgimgJsdelivr":"https://cdn.jsdelivr.net/gh/myreaderx7/cdn59@2020_6/2020/10/09/04-04-47-036_6fe80aa9eb02ac21.webp","destWidth":397,"destHeight":395,"sourceBytes":10507,"destBytes":7592,"author":"","articleImgCdnMap":{"http://img.100weidu.com/mmbiz_jpg/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDBC6qAJR3rAoz0r9Fa4RXHHhgugooTJjrZEKVqUz7PP9kbOroWICnjg?imageView2/1/w/600":"https://cdn.jsdelivr.net/gh/myreaderx7/cdn59@2020_6/2020/10/09/04-04-47-036_6fe80aa9eb02ac21.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRD05PzkAEVDOWIOib0ro8KVicwwcVZWCAmJyyOCJsy9uUkCeJInLn446CA/640?wx_fmt=jpeg":"https://cdn.jsdelivr.net/gh/myreaderx21/cdn66@2020_5/2020/10/09/04-04-54-701_2b6e03c06f93a931.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDibsbBFdyj4Hs89NDgdb8hAml2LrcjlguiaGljCAJ95icwLtzE9ekulGDw/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx5oss/cdn63@2020_2/2020/10/09/04-05-57-980_b2e115afd0f42176.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/l4sfibEYR5pUf979ZOSA6TqRcPELjZicZo5sJYxcicsfdcNjPpiaE8S9RyQJET6FF1iaqnx3ptoXFnx3UgCsIn6wE3w/640?wx_fmt=gif":"https://cdn.jsdelivr.net/gh/myreaderx24/cdn73@2020_2/2020/10/09/04-06-57-133_35192a1fc2ea4821.webp","http://www.jintiankansha.me/rss_static/32521/BrDLFR55zs":null},"publishedOrCreatedDate":1602216285147}],"record":{"createdTime":"2020-10-09 12:04:45","updatedTime":"2020-10-09 12:04:45","feedId":1597,"fetchDate":"Fri, 09 Oct 2020 04:04:45 +0000","fetchMs":194,"handleMs":9,"totalMs":133458,"newArticles":0,"totalArticles":5,"status":1,"type":0,"ip":"48b55560af3da9c096a2702d0ffd5d16","hostName":"us-015*","requestId":"4d8da666cdbb49bfacce1b2b7e2a31d9_1597","contentType":"application/rss+xml","totalBytes":264686,"bgimgsTotal":1,"bgimgsGithubTotal":1,"articlesImgsTotal":5,"articlesImgsGithubTotal":4,"successGithubMap":{"myreaderx7":1,"myreaderx21":1,"myreaderx24":1,"myreaderx5oss":1},"failGithubMap":{}},"feed":{"createdTime":"2020-08-24 21:31:31","updatedTime":"2020-09-01 09:49:33","id":1597,"name":"界面","url":"http://feedmaker.kindle4rss.com/feeds/wowjiemian.weixin.xml","subscriber":null,"website":null,"icon":"http://www.sogou.com/images/logo/new/favicon.ico?v=4","icon_jsdelivr":"https://cdn.jsdelivr.net/gh/myreaderx63/cdn50@2020_1/2020/09/01/01-49-34-215_d24121c9beed1de6.ico","description":"界面是中国最大的商业新闻和社交平台，只服务于独立思考的人群。","weekly":null,"link":null},"noPictureArticleList":[{"createdTime":"2020-10-09 12:06:58","updatedTime":"2020-10-09 12:06:58","id":null,"feedId":1597,"linkMd5":"57c2f7e6ee7f588aab50e11afadf5f21"}],"tmpCommonImgCdnBytes":7592,"tmpBodyImgCdnBytes":257094,"tmpBgImgCdnBytes":0,"extra4":{"start":1602216284855,"total":0,"statList":[{"spend":283,"msg":"获取xml内容"},{"spend":9,"msg":"解释文章"},{"spend":0,"msg":"上传封面图到cdn"},{"spend":0,"msg":"修正封面图上传失败重新上传"},{"spend":130489,"msg":"正文链接上传到cdn"}]},"extra5":5,"extra6":5,"extra7ImgCdnFailResultVector":[{"code":1,"isDone":false,"source":"http://www.jintiankansha.me/rss_static/32521/BrDLFR55zs","sourceStatusCode":405,"sourceBytes":0,"destBytes":0,"feedId":1597,"totalSpendMs":404,"convertSpendMs":0,"createdTime":"2020-10-09 12:04:49","host":"us-035*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[405],"destSize":"0","sourceSize":"0"},{"code":1,"isDone":false,"source":"http://www.jintiankansha.me/rss_static/32521/BrDLFR55zs","sourceStatusCode":405,"sourceBytes":0,"destBytes":0,"feedId":1597,"totalSpendMs":927,"convertSpendMs":0,"createdTime":"2020-10-09 12:04:50","host":"us-004*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[405],"destSize":"0","sourceSize":"0"},null,null,{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/l4sfibEYR5pUf979ZOSA6TqRcPELjZicZo5sJYxcicsfdcNjPpiaE8S9RyQJET6FF1iaqnx3ptoXFnx3UgCsIn6wE3w/640?wx_fmt=gif","sourceStatusCode":403,"sourceBytes":0,"destBytes":0,"feedId":1597,"totalSpendMs":2028,"convertSpendMs":0,"createdTime":"2020-10-09 12:05:48","host":"us-55*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","extra22GetBytesInfo":"2、Referer字段 ： http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","extra23historyStatusCode":[403,403],"destSize":"0","sourceSize":"0"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDibsbBFdyj4Hs89NDgdb8hAml2LrcjlguiaGljCAJ95icwLtzE9ekulGDw/640?wx_fmt=png","sourceStatusCode":403,"sourceBytes":0,"destBytes":0,"feedId":1597,"totalSpendMs":1556,"convertSpendMs":0,"createdTime":"2020-10-09 12:05:49","host":"us-55*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","extra22GetBytesInfo":"2、Referer字段 ： http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","extra23historyStatusCode":[403,403],"destSize":"0","sourceSize":"0"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/l4sfibEYR5pUf979ZOSA6TqRcPELjZicZo5sJYxcicsfdcNjPpiaE8S9RyQJET6FF1iaqnx3ptoXFnx3UgCsIn6wE3w/640?wx_fmt=gif","sourceStatusCode":403,"sourceBytes":0,"destBytes":0,"feedId":1597,"totalSpendMs":2028,"convertSpendMs":0,"createdTime":"2020-10-09 12:05:48","host":"us-55*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","extra22GetBytesInfo":"2、Referer字段 ： http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","extra23historyStatusCode":[403,403],"destSize":"0","sourceSize":"0"}],"extra10_invalidATagHrefValue":{},"extra111_proxyServerAndStatMap":{"http://europe-56.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[null]},"http://us-018.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[403]},"http://us-55.herokuapp.com/":{"failCount":2,"successCount":1,"resultList":[200,403,403]},"http://us-004.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[405]},"http://us-019.herokuapp.com/":{"failCount":0,"successCount":2,"resultList":[200,200]},"http://us-034.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[null]},"http://us-035.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[405]}},"extra12ImgCdnSuccessResultVector":[{"code":1,"isDone":false,"source":"http://img.100weidu.com/mmbiz_jpg/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDBC6qAJR3rAoz0r9Fa4RXHHhgugooTJjrZEKVqUz7PP9kbOroWICnjg?imageView2/1/w/600","sourceStatusCode":200,"destWidth":397,"destHeight":395,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx7/cdn59@2020_6/2020/10/09/04-04-47-036_6fe80aa9eb02ac21.webp","sourceBytes":10507,"destBytes":7592,"targetWebpQuality":75,"feedId":1597,"totalSpendMs":2648,"convertSpendMs":8,"createdTime":"2020-10-09 12:04:45","host":"us-019*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21,57c2f7e6ee7f588aab50e11afadf5f21","githubUser":"myreaderx7","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"destSize":"7.4 KB","compressRate":"72.3%","sourceSize":"10.3 KB"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_jpg/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRD05PzkAEVDOWIOib0ro8KVicwwcVZWCAmJyyOCJsy9uUkCeJInLn446CA/640?wx_fmt=jpeg","sourceStatusCode":200,"destWidth":700,"destHeight":398,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx21/cdn66@2020_5/2020/10/09/04-04-54-701_2b6e03c06f93a931.webp","sourceBytes":17128,"destBytes":10850,"targetWebpQuality":75,"feedId":1597,"totalSpendMs":5617,"convertSpendMs":16,"createdTime":"2020-10-09 12:04:49","host":"us-55*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","githubUser":"myreaderx21","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"destSize":"10.6 KB","compressRate":"63.3%","sourceSize":"16.7 KB"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/l4sfibEYR5pUwnbtyzkwvEWNRT1RwibYRDibsbBFdyj4Hs89NDgdb8hAml2LrcjlguiaGljCAJ95icwLtzE9ekulGDw/640?wx_fmt=png","sourceStatusCode":200,"destWidth":700,"destHeight":372,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx5oss/cdn63@2020_2/2020/10/09/04-05-57-980_b2e115afd0f42176.webp","sourceBytes":286513,"destBytes":24550,"targetWebpQuality":75,"feedId":1597,"totalSpendMs":7584,"convertSpendMs":21,"createdTime":"2020-10-09 12:05:51","host":"us-019*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","githubUser":"myreaderx5oss","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"destSize":"24 KB","compressRate":"8.6%","sourceSize":"279.8 KB"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/l4sfibEYR5pUf979ZOSA6TqRcPELjZicZo5sJYxcicsfdcNjPpiaE8S9RyQJET6FF1iaqnx3ptoXFnx3UgCsIn6wE3w/640?wx_fmt=gif","sourceStatusCode":200,"destWidth":640,"destHeight":360,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx24/cdn73@2020_2/2020/10/09/04-06-57-133_35192a1fc2ea4821.webp","sourceBytes":602202,"destBytes":221694,"targetWebpQuality":75,"feedId":1597,"totalSpendMs":7798,"convertSpendMs":823,"createdTime":"2020-10-09 12:06:50","host":"us-019*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E7%95%8C%E9%9D%A2+%E6%B5%81%E6%84%9F%E7%96%AB%E8%8B%97%E2%80%9C%E8%B6%85%E7%BA%A7%E5%B9%B4%E2%80%9D%EF%BC%8C%E5%93%AA%E4%BA%9B%E4%B8%8A%E5%B8%82%E5%85%AC%E5%8F%B8%E6%9C%89%E5%AE%9E%E8%B4%A8%E5%88%A9%E5%A5%BD%EF%BC%9F","linkMd5ListStr":"57c2f7e6ee7f588aab50e11afadf5f21","githubUser":"myreaderx24","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"destSize":"216.5 KB","compressRate":"36.8%","sourceSize":"588.1 KB"}],"successGithubMap":{"myreaderx7":1,"myreaderx21":1,"myreaderx24":1,"myreaderx5oss":1},"failGithubMap":{}}